
4D Molecular Therapeutics, Inc.
USD13.66
+0.79 (+6.09%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.87
Prev. Close
$12.88
Day Low
$12.69
Day High
$13.73
52W Low
$3.68
52W High
$13.73
Market Cap
$0.71B
Volume
0.25M
4D Molecular Therapeutics Presents Non-Human Primate Preclinical Data at ASGCT on the 4D-150 Product Candidate for wet AMD and DME